McKesson Corporation
594.02
8.94 (1.53%)
At close: Jan 14, 2025, 3:59 PM
593.73
-0.05%
After-hours Jan 14, 2025, 07:00 PM EST

McKesson Corporation Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012Dec 31, 2011
International Segment Revenue 3.71B 3.55B 3.64B 3.48B 3.47B 3.36B 4.45B 6.24B 6.55B 8.53B 9.46B 9.11B 9.25B 17.15B 9.27B 9.54B 1.80B 2.21B 2.14B 2.06B 1.90B 1.96B 2.01B 1.95B 1.70B 1.44B 1.44B 1.56B 1.53B 1.38B 1.36B 1.46B 1.47B 1.36B 1.07B 874.00M 873.00M 795.00M 760.00M
International Segment Revenue Growth +4.54% -2.50% +4.72% +0.20% +3.12% -24.41% -28.67% -4.76% -23.22% -9.83% +3.85% -1.48% -46.09% +84.97% -2.80% +429.71% -18.32% +2.99% +4.13% +8.04% -2.66% -2.83% +3.29% +14.39% +18.26% +0.28% -8.18% +2.36% +10.80% +1.25% -6.84% -0.34% +8.11% +26.94% +22.31% +0.11% +9.81% +4.61% n/a
Medical-Surgical Solutions Segment Revenue 2.95B 2.84B 3.03B 2.83B 2.61B 2.69B 2.99B 2.84B 2.59B 2.87B 3.08B 3.12B 2.53B 2.71B 3.05B 2.53B 45.06B 46.27B 46.92B 45.98B 44.16B 40.90B 44.28B 41.61B 40.98B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Medical-Surgical Solutions Segment Revenue Growth +3.91% -6.40% +6.95% +8.54% -2.90% -9.95% +5.03% +9.68% -9.81% -6.75% -1.34% +23.58% -6.75% -11.23% +20.57% -94.38% -2.62% -1.38% +2.05% +4.11% +7.99% -7.64% +6.41% +1.54% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Prescription Technology Solutions Revenue 1.26B 1.18B 1.21B 1.14B 1.24B 1.18B 1.12B 1.02B 1.07B 1.02B 1.03B 932.00M 881.00M 1.45B 777.00M 668.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Prescription Technology Solutions Revenue Growth +7.20% -2.07% +5.70% -8.36% +5.25% +5.44% +10.12% -4.50% +4.51% -1.07% +10.62% +5.79% -39.03% +85.97% +16.32% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
U.S. Pharmaceutical Segment Revenue 85.73B 68.79B 73.02B 69.77B 67.16B 61.68B 61.93B 60.06B 56.95B 53.68B 55.04B 53.41B 50.02B 46.65B 49.49B 48.07B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
U.S. Pharmaceutical Segment Revenue Growth +24.62% -5.80% +4.67% +3.88% +8.89% -0.42% +3.12% +5.46% +6.09% -2.48% +3.05% +6.78% +7.22% -5.75% +2.97% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019Mar 31, 2018Mar 31, 2017Mar 31, 2016
International Segment Revenue 14.13B 20.60B 36.34B 35.97B 38.34B 38.02B 38.41B 34.10B 32.63B
International Segment Revenue Growth -31.40% -43.33% +1.06% -6.20% +0.84% -1.02% +12.63% +4.52% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.50B 1.90B 2.09B 2.51B 2.09B 1.87B 1.96B 1.90B 1.95B 1.96B 2.53B 3.10B 2.67B 2.23B 2.22B 2.29B 2.24B 2.10B 2.40B 2.54B 2.22B 2.15B 2.86B 1.93B 1.80B 1.91B 2.22B 1.98B 2.01B 1.96B 2.01B 1.98B 1.89B 1.94B 1.91B 1.95B 1.89B 1.92B 2.07B
Selling, General, and Administrative Revenue Growth +32.08% -9.37% -16.56% +19.79% +11.87% -4.79% +3.21% -2.41% -0.46% -22.60% -18.49% +16.34% +19.58% +0.36% -2.92% +2.41% +6.32% -12.44% -5.21% +14.24% +3.35% -24.98% +48.14% +7.45% -5.77% -13.98% +11.79% -1.24% +2.29% -2.14% +1.31% +5.04% -2.53% +1.36% -2.20% +3.28% -1.41% -7.26% n/a
Research and Development Revenue n/a n/a 77.00M n/a n/a n/a 89.00M n/a n/a n/a 70.00M n/a n/a n/a 74.00M n/a n/a n/a 96.00M n/a n/a n/a 71.00M n/a n/a n/a 125.00M n/a n/a n/a 341.00M n/a n/a n/a 392.00M n/a n/a n/a 392.00M
Research and Development Revenue Growth n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a

Create Price Alert on MCK

Your price alert will notify you when the stock price is above 594.02.

Add to Watchlist